1. Home
  2. RGEN vs KVYO Comparison

RGEN vs KVYO Comparison

Compare RGEN & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KVYO
  • Stock Information
  • Founded
  • RGEN 1981
  • KVYO 2012
  • Country
  • RGEN United States
  • KVYO United States
  • Employees
  • RGEN N/A
  • KVYO N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KVYO
  • Sector
  • RGEN Health Care
  • KVYO
  • Exchange
  • RGEN Nasdaq
  • KVYO Nasdaq
  • Market Cap
  • RGEN 8.2B
  • KVYO 8.3B
  • IPO Year
  • RGEN N/A
  • KVYO 2023
  • Fundamental
  • Price
  • RGEN $142.03
  • KVYO $33.67
  • Analyst Decision
  • RGEN Buy
  • KVYO Buy
  • Analyst Count
  • RGEN 10
  • KVYO 17
  • Target Price
  • RGEN $188.38
  • KVYO $35.56
  • AVG Volume (30 Days)
  • RGEN 778.8K
  • KVYO 913.8K
  • Earning Date
  • RGEN 10-29-2024
  • KVYO 11-05-2024
  • Dividend Yield
  • RGEN N/A
  • KVYO N/A
  • EPS Growth
  • RGEN N/A
  • KVYO N/A
  • EPS
  • RGEN N/A
  • KVYO N/A
  • Revenue
  • RGEN $602,354,000.00
  • KVYO $809,631,000.00
  • Revenue This Year
  • RGEN $0.08
  • KVYO $33.75
  • Revenue Next Year
  • RGEN $12.97
  • KVYO $25.84
  • P/E Ratio
  • RGEN N/A
  • KVYO N/A
  • Revenue Growth
  • RGEN N/A
  • KVYO 38.38
  • 52 Week Low
  • RGEN $110.45
  • KVYO $21.26
  • 52 Week High
  • RGEN $211.13
  • KVYO $37.36
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 45.65
  • KVYO 66.86
  • Support Level
  • RGEN $135.88
  • KVYO $30.64
  • Resistance Level
  • RGEN $150.72
  • KVYO $31.69
  • Average True Range (ATR)
  • RGEN 5.47
  • KVYO 1.24
  • MACD
  • RGEN -0.88
  • KVYO 0.11
  • Stochastic Oscillator
  • RGEN 36.09
  • KVYO 77.57

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: